摘要:
The invention includes a dual lumen catheter which is a unitary, elongated, flexible catheter tube that is substantially circular in cross-section. The catheter tube has an outer wall member forming a tube having a proximal end and a distal end portion adapted for insertion within a vein or artery of a patient. The outer wall member defines first and second coaxial lumens that are separated by an inner common support wall which is substantially circular and joins the outer wall. The first lumen extends longitudinally between the opposed distal and proximal ends of the catheter tube and terminates coextensive with the distal end portion of the catheter tube. The second lumen extends longitudinally from the proximal end of the catheter tube and terminates proximal to the distal end portion of the catheter tube. The second lumen is crescent-shaped in cross-section and substantially surrounds the first lumen. The cross-sectional areas of the first and second lumens are approximately equal.
摘要:
Compounds of formula in free or salt or solvate form, whereAr is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
摘要:
The invention provides methods for the treatment of cognitive disorders utilizing specific 5-HT4 receptor agonist compounds, in particular, methods utilizing these compounds in combination with other agents, specifically acetylcholinesterase inhibitors, for the treatment of Alzheimer's disease and other cognitive disorders.
摘要:
Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
摘要:
Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
摘要:
Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.